Soluble LRIG1 inhibits cancer cell growth

被引：0
|
作者：
Goldoni, S.
Iozzo, R.
Kay, P.
Campbell, S.
McQuillan, A.
Agnew, C.
Zhu, J.
Keen, D.
Reed, C.
Iozzo, R.
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Shriners Hosp Children, Portland, OR 97201 USA
来源：
MATRIX BIOLOGY | 2006年 / 25卷
关键词：
D O I：
10.1016/j.matbio.2006.08.112
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity
    Goldoni, S.
    Iozzo, R. A.
    Kay, P.
    Campbell, S.
    McQuillan, A.
    Agnew, C.
    Zhu, J-X
    Keene, D. R.
    Reed, C. C.
    Iozzo, R. V.
    ONCOGENE, 2007, 26 (03) : 368 - 381
  • [2] A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity
    S Goldoni
    R A Iozzo
    P Kay
    S Campbell
    A McQuillan
    C Agnew
    J-X Zhu
    D R Keene
    C C Reed
    R V Iozzo
    Oncogene, 2007, 26 : 368 - 381
  • [3] Resveratrol inhibits glioma cell growth via targeting LRIG1
    Liu, Lianfang
    Zhang, Yonghua
    Zhu, Kai
    Song, Lili
    Tao, Minxian
    Huang, Pan
    Pan, Yingying
    JOURNAL OF BUON, 2018, 23 (02): : 403 - 409
  • [4] LRIG1 expression in colorectal cancer
    Ljuslinder, Ingrid
    Golovleva, Irina
    Palmqvist, Richard
    Oberg, Ake
    Stenling, Roger
    Jonsson, Yvonne
    Hedman, Hakan
    Henriksson, Roger
    Malmer, Beatrice
    ACTA ONCOLOGICA, 2007, 46 (08) : 1118 - 1122
  • [5] LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer
    Thomasson, Marcus
    Wang, Baofeng
    Hammarsten, Peter
    Dahlman, Anna
    Persson, Jenny Liao
    Josefsson, Andreas
    Stattin, Par
    Granfors, Torvald
    Egevad, Lars
    Henriksson, Roger
    Bergh, Anders
    Hedman, Hakan
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (12) : 2843 - 2852
  • [6] The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
    Johansson, M.
    Oudin, A.
    Tiemann, K.
    Bernard, A.
    Keunen, O.
    Fack, F.
    Golebiewska, A.
    Stieber, D.
    Wang, B.
    Hedman, H.
    Niclou, S. P.
    NEURO-ONCOLOGY, 2012, 14 : 15 - 16
  • [7] The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
    Johansson, Mikael
    Oudin, Anais
    Tiemann, Katja
    Bernard, Amandine
    Golebiewska, Anna
    Keunen, Olivier
    Fack, Fred
    Stieber, Daniel
    Wang, Baofeng
    Hedman, Hakan
    Niclou, Simone P.
    NEURO-ONCOLOGY, 2013, 15 (09) : 1200 - 1211
  • [8] LRIG1 expression and colorectal cancer prognosis
    Bakherad, Maryam
    Salimi, Mahdieh
    Angaji, Seyed Abdolhamid
    Mahjoubi, Frouzandeh
    Majidizadeh, Tayebeh
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [9] Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity
    Lei Chang
    Runlin Shi
    Tao Yang
    Fan Li
    Guohao Li
    Yonglian Guo
    Bin Lang
    Weimin Yang
    Qianyuan Zhuang
    Hua Xu
    Journal of Experimental & Clinical Cancer Research, 32
  • [10] Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity
    Chang, Lei
    Shi, Runlin
    Yang, Tao
    Li, Fan
    Li, Guohao
    Guo, Yonglian
    Lang, Bin
    Yang, Weimin
    Zhuang, Qianyuan
    Xu, Hua
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
12345